Direct-to-consumer genetic testing exploded on to the scene a few years ago, but as Malorye Allison writes at Nature Biotechnology, many of those firms have had to reinvent themselves in the wake of waning consumer interest, increased regulatory attention, and other pressures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.